Cargando…
miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3
T-cell lymphoblastic lymphoma (T-LBL) is an aggressive malignancy with poor prognosis due to frequent relapses. Previous studies have reported an association of the disease with abnormal chromosomal rearrangements, DNA copy number alterations and mutations in critical signaling factors, such as thos...
Autores principales: | Wang, Li, Sui, Minghua, Wang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691266/ https://www.ncbi.nlm.nih.gov/pubmed/31322185 http://dx.doi.org/10.3892/mmr.2019.10451 |
Ejemplares similares
-
MiR-338-3p improved lung adenocarcinoma by AKAP12 suppression
por: Chang, Jin, et al.
Publicado: (2019) -
miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5
por: Zhang, Xiaoqian, et al.
Publicado: (2017) -
HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3
por: Sun, Jianrui, et al.
Publicado: (2022) -
MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation
por: Howe, James R., et al.
Publicado: (2017) -
Correction: HOXA-AS2 enhances GBM cell malignancy by suppressing miR-2116-3p thereby upregulating SERPINA3
por: Sun, Jianrui, et al.
Publicado: (2022)